According to a newly published market research report by 24LifeSciences, global Itopride Hydrochloride Tablets market was valued at USD 320 million in 2024 and is projected to reach USD 450 million by 2032, growing at a compound annual growth rate (CAGR) of 4.3% during the forecast period 2025–2032. Itopride Hydrochloride, a gastrointestinal prokinetic agent that combines dopamine D2...